Patents by Inventor Raj Ramnik Jain

Raj Ramnik Jain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL FORMULATION FOR TREATING COPPER METABOLISM-ASSOCIATED DISEASES OR DISORDERS
    Publication number: 20240100088
    Abstract: This disclosure relates to novel formulations of bis-choline tetrathiomolybdate useful for treating a copper metabolism-associated disease or disorder, such as Wilson disease (WD). For example, this disclosure relates to low dose formulations of bis-choline tetrathiomolybdate.
    Type: Application
    Filed: January 31, 2022
    Publication date: March 28, 2024
    Applicant: Alexion Pharmaceuticals, Inc.
    Inventors: Justin Lockheart Burt, David Jenson Chen, Todd Anthony Stutzman, Allissa Robin Kerner, Joseph Michael Schnitz, Raj Ramnik Jain
  • FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF
    Publication number: 20230285417
    Abstract: This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and pharmaceutical compositions thereof. Also disclosed herein are methods of making the pharmaceutical compositions of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof.
    Type: Application
    Filed: July 20, 2021
    Publication date: September 14, 2023
    Inventors: Paul Steven Watson, Bret Berner, Padma Narayan, Xiaoxia Chen, Todd Anthony Stutzman, Jianing Meng, Carolyn Wilkerson, Raj Ramnik Jain
  • FORMULATIONS OF 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROID AND METHODS OF USE THEREOF
    Publication number: 20230057130
    Abstract: This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and pharmaceutical compositions thereof. Also disclosed herein are methods of making the pharmaceutical compositions of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof.
    Type: Application
    Filed: January 19, 2022
    Publication date: February 23, 2023
    Inventors: Paul Steven Watson, Bret Berner, Padma Narayan, Xiaoxia Chen, Todd Anthony Stutzman, Jianing Meng, Carolyn Wilkerson, Raj Ramnik Jain